Clinical trial Recruiting at 1 site Interventional Ages 20 and up

Improving health communication in nursing homes using AI technology

Official title: The Effectiveness of Artificial Intelligence Family Involvement Generative Agent (AIFIGA) Program on Nursing Home Nursing Staff and Family and Residents'Health

Run by Chang Gung Memorial Hospital · NCT06574438 · Data updated 2026-11-12

This study is testing a new AI program to see if it can help nursing home staff, residents, and their families communicate better and improve health outcomes after COVID-19.

Quick facts

Study typeInterventional
Ages20 Years and up
SexAll
Enrollment210 (estimated)
SponsorChang Gung Memorial Hospital
Academic / other
Locations1 site (Hsinchu)
StatusRecruiting
StartedSeptember 24, 2024
Main results expectedJuly 2027
Study endsJuly 2027
Registry record updatedFebruary 9, 2026
Trial IDNCT06574438 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include nursing home residents aged 60 and older, their family caregivers aged 20 and above, and nursing staff who can communicate in Mandarin or Taiwanese.

Probably not a fit

Patients who do not meet the age or communication criteria, or those with severe cognitive impairments (MMSE score below the specified thresholds), may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the effectiveness of the Artificial Intelligence Family Involvement Generative Agent (AIFIGA) program designed to enhance communication between nursing staff, residents, and their families in nursing homes. Over 18 months, the program will be developed using a mixed methods approach, incorporating observations and interviews to understand communication needs post-COVID-19. The AIFIGA program aims to facilitate real-time, interactive communication to improve health outcomes for all parties involved.

Why it matters

Potential benefit: If successful, this program could significantly improve the health and well-being of nursing home residents and enhance the support provided by their families and nursing staff.

How similar studies have gone: While the use of AI in healthcare communication is emerging, this specific approach has not been widely tested, making it a novel initiative.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

All resident-caregiver pairs meeting the inclusion criteria will be invited to join the study.

1. residents aged ≥ 60 years, resident's family were aged equal or higher than 20 years.
2. both residents and family can communicate in Mandarin or Taiwanese
3. residents have a Mini-Mental State Examination (MMSE) score equal to or higher than 16 for residents with no formal education or higher than 24 for residents with at least a primary school education
4. both residents and family agree to participate
5. the family is a significant member of the resident, such as a caregiver.

For nurses and nursing aides:

1. working in the selected nursing home who agree to participate in our program.
2. aged equal or higher than 20 years.

Exclusion Criteria:

\-

Where it's running

  • Catholic Mercy Hospital Attached Nursing Home
    Hsinchu, Taiwan
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • AI-assisted whole-course management for safe medicine use in advanced solid tumors

    A real-world study compares a smartphone-based digital management system with usual care to see if it reduces drug-related problems and healthcare needs for adults with advanced solid tumors receiving cancer therapy.

    Recruiting at 2 sites Tianjin Medical University Second Hospital · Tianjin, Tianjin Municipality and 1 other locations · NCT07917351

  • Digitally Enabled Districts 2.0: Aimed at Improving Maternal and Neonatal Care in Garut

    A stepped-wedge trial tests whether an integrated digital health ecosystem helps 45 local clinics in Garut improve the completeness and timeliness of maternal and neonatal care.

    Recruiting Summit Institute for Development, Indonesia · Mataram, West Nusa Tenggara · NCT07842224

  • Preventing another ischemic stroke with a smart bracelet and app

    This study tests whether a digital prevention program using a wearable and a mobile app can help people who recently had an ischemic stroke reduce the chance of another stroke and improve risk-factor control.

    Recruiting Affiliated Hospital of Nantong University · Nantong, Jiangsu · NCT07825311

  • Digital Recovery Support for Black adults with Alcohol Use Disorder in Detroit

    This study tests whether a smartphone-based digital recovery program helps Black or African American adults in Detroit maintain their recovery from alcohol use disorder.

    Recruiting Brandeis University · Detroit, Michigan · NCT07724275

  • Can family members spot delirium signs in ICU patients?

    Family members who know the patient well try a quick delirium check after visiting in the ICU, to see if their observations add information beyond routine nurse screenings.

    Recruiting Shanghai Zhongshan Hospital · Shanghai, Shanghai Municipality · NCT07694687

  • Remote-patient monitoring in diabetes care shows real-world outcomes

    A real-world, pre-post observational study at Steno Diabetes Center Copenhagen tests whether adding remote-patient-monitoring within the EHR can maintain glycemic outcomes over two years for about 12,000 people with diabetes compared with prior ambulatory care.

    Recruiting Steno Diabetes Center Copenhagen · Herlev · NCT07617519

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.